Eastwood Eye Surgery 2025 JUNE Optometry Seminar
Date: 23/06/2025 (AEST)
Venue: Crowne Plaza 7/11 Talavera Rd, North Ryde NSW 2113, NSW, 2113
Provider: Eastwood Eye Surgery
Contact: Kylie, [E] office@eastwoodeyesurgery.com.au, [P] 98745947
Activity Outline
Eastwood Eye Surgery is a longstanding ophthalmic practice providing dedicated eye care to patients for over 50 years. We have recently relocated to a state-of-the-art facility, boasting modern, sleek interiors, equipped with the latest technology to ensure the very best eye care for all our patients. Our ophthalmologists have expertise in all areas of ophthalmology, including cataract, glaucoma and retinal diseases. Join Dr Gagan Khannah, Dr Rajiv Shah, Dr Andrew Kaines and Dr Dov Hersh for an exciting night of presentations, interactive displays, discussion and socialising.
Learning Objectives
- Understand the latest Glaucoma innovations and research
- Recognize the way Preserflo shunts are changing Glaucoma surgical treatment
- Understand how Anti-VEGF injections work and what common conditions it treats
- Understand limitations of Anti-VEGF
- Understand the pathophysiology of GA and what to tell patients regarding the treatment of GA in the Australian context
- Be familiar with the trial outcome of complement inhibitors used in the treatment of GA
- Gain an understanding of the potential side effects of complement inhibitors used in the treatment of GA-
- Understand the features of suspicious pigmented retinal lesion & systemic risk with a number of pigmented retinal lesions
- Understanding various types of Presbyopia correcting IOLs-
- Differentiate between Diffractive and Refractive IOL
- Understand the latest developments in EDOF IOLs
- Understand the importance of post-operative monitoring
- Have gained some clinical pearls on patient counselling and treatment
Max CPD hours awarded: 2
Session Information
| Name |
|---|
| Highlights from the 2025 ANZGS & 2 year follow up data on Preserflo Shunts |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Unusual Reasons for Anti-VEGF Injections |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Part 1: An update on treatment for GA: Are we there yet? Part 2: Pigmented retinal lesions when to refer |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| The very latest in IOL technology from ASCRS |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |